Evidence map›Paper›PMID 25875427›Full record

ArticlePloS one2015

O-glycosylation in cell wall proteins in Scedosporium prolificans is critical for phagocytosis and inflammatory cytokines production by macrophages.

Mariana I D S Xisto, Vera C B Bittencourt, Livia Cristina Liporagi-Lopes, Rosa M T Haido, Morena S A Mendonça, Guilherme Sassaki, Rodrigo T Figueiredo, Maria Teresa V Romanos, Eliana Barreto-Bergter

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Extracellular Vesicles fromJournal of fungi (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Fibronectin-binding molecules of Scedosporium apiospermum: focus on adhesive events.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  6. An Alpha-Glucan fromJournal of fungi (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Microorganisms · 2022
    Review
  9. Article
  10. Article
  11. The Host Immune Response toJournal of fungi (Basel, Switzerland) · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Peptidorhamnomannans FromFrontiers in cellular and infection microbiology · 2020
    Article
  16. Article
  17. Article
  18. Glucosylceramides FromFrontiers in microbiology · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Mariana I D S XistoDepartamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, UFRJ, Rio de Janeiro, Rio de Janeiro, Brazil.
Vera C B BittencourtDepartamento de Microbiologia e Parasitologia, Instituto Biomédico, UNIRIO, Rio de Janeiro, Rio de Janeiro, Brazil.
Livia Cristina Liporagi-LopesDepartamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, UFRJ, Rio de Janeiro, Rio de Janeiro, Brazil.
Rosa M T HaidoDepartamento de Microbiologia e Parasitologia, Instituto Biomédico, UNIRIO, Rio de Janeiro, Rio de Janeiro, Brazil.
Morena S A MendonçaInstituto de Ciências Biomédicas, UFRJ, Rio de Janeiro, Rio de Janeiro, Brazil.
Guilherme SassakiDepartamento de Bioquímica e Biologia Molecular, UFRP, Curitiba, Paraná, Brazil.
Rodrigo T FigueiredoCampus de Xerém, Instituto de Ciências Biomédicas, UFRJ, Rio de Janeiro, Rio de Janeiro, Brazil.
Maria Teresa V RomanosDepartamento de Virologia, Instituto de Microbiologia Paulo de Góes, UFRJ, Rio de Janeiro, Rio de Janeiro, Brazil.
Eliana Barreto-BergterDepartamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, UFRJ, Rio de Janeiro, Rio de Janeiro, Brazil.
Universidade Federal do Estado do Rio de Janeiro · BRUniversidade Federal do Rio de Janeiro · BRUniversidade do Estado do Rio de Janeiro · BRUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we analyze the importance of O-linked oligosaccharides present in peptidorhamnomannan (PRM) from the cell wall of the fungus Scedosporium prolificans for recognition and phagocytosis of conidia by macrophages. Adding PRM led to a dose-dependent inhibition of conidia phagocytosis, whereas de-O-glycosylated PRM did not show any effect. PRM induced the release of macrophage-derived antimicrobial compounds. However, O-linked oligosaccharides do not appear to be required for such induction. The effect of PRM on conidia-induced macrophage killing was examined using latex beads coated with PRM or de-O-glycosylated PRM. A decrease in macrophage viability similar to that caused by conidia was detected. However, macrophage killing was unaffected when beads coated with de-O-glycosylated PRM were used, indicating the toxic effect of O-linked oligosaccharides on macrophages. In addition, PRM triggered TNF-α release by macrophages. Chemical removal of O-linked oligosaccharides from PRM abolished cytokine induction, suggesting that the O-linked oligosaccharidic chains are important moieties involved in inflammatory responses through the induction of TNF-α secretion. In summary, we show that O-glycosylation plays a role in the recognition and uptake of S. prolificans by macrophages, killing of macrophages and production of pro- inflammatory cytokines.

Indexed as

AnimalsCells, CulturedFemaleFlow CytometryGlycoproteinsGlycosylationInterleukin-10MacrophagesMaleMiceMice, Inbred BALB CMicroscopy, FluorescenceNitric OxidePhagocytosisRabbitsScedosporiumGlycoproteinsInterleukin-10Nitric Oxidepeptido-rhamnomannanTumor Necrosis Factor-alpha

Identifiers

PMID25875427
PMCPMC4396840
OpenAlexW2094561178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.